Description
Cello Health plc, together with its subsidiaries, offers marketing services in the United Kingdom, the rest of Europe, the United States, and internationally. It operates in two segments, Cello Health and Cello Signal. The Cello Health segment offers market research, consulting, and communications services principally to the pharmaceutical and healthcare clients. The Cello Signal segment offers market research and direct communications services principally to consumer-facing clients. Cello Health plc was incorporated in 2004 and is based in London, the United Kingdom. As of August 11, 2020, Cello Health plc operates as a subsidiary of Value Demonstration UK Holdings Limited.
